Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?
Abstract This article explores how the African Vaccine Manufacturing Accelerator can support the sustainable production of vaccines in Africa. It highlights the value of the accelerator in relation to the Regional Vaccine Manufacturing Collaborative. The author proposes that this novel financing ins...
Gespeichert in:
Veröffentlicht in: | International health 2024-05, Vol.16 (5), p.568-570 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 570 |
---|---|
container_issue | 5 |
container_start_page | 568 |
container_title | International health |
container_volume | 16 |
creator | Awosusi, Abiodun E |
description | Abstract
This article explores how the African Vaccine Manufacturing Accelerator can support the sustainable production of vaccines in Africa. It highlights the value of the accelerator in relation to the Regional Vaccine Manufacturing Collaborative. The author proposes that this novel financing instrument should be well-designed and implemented in line with the targets of the Partnerships for African Vaccine Manufacturing. It should not be a decoupling tool to appease the institutional environment of the global vaccine market, but a sustainable demonstration of the goodwill and commitment of political and technical leaders to ensure equitable access to routine and epidemic-related vaccines in Africa. |
doi_str_mv | 10.1093/inthealth/ihae032 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11375562</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/inthealth/ihae032</oup_id><sourcerecordid>3051940455</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-2f059c5a39c42f3ad6d040c159cfb8c5270cae9b36c9323350ec941fdcd798813</originalsourceid><addsrcrecordid>eNqNkTFPwzAQhS0EoqXwA1hQRgZC7ThO4qmqKqCVQCzAal0vTmOUOMVOkPj3pGqJYGOy5ffuu_M9Qi4ZvWVU8qmxbamhasupKUFTHh2RMcvSJOQxFcfDnfEROfP-ndIk40l0SkY8S1kkkmxMlisf9JBgXjiDYIM3QDRWB09guwKw7Zyxm2COqCvtoG1cAEGusem21U6oNZZgja9n5-SkgMrri8M5Ia_3dy-LZfj4_LBazB9D5Ey2YVRQIVEAlxhHBYc8yWlMkfWPxTpDEaUUQcs1T1DyiHNBNcqYFTnmqcwyxidktuduu3Wtc9S2dVCprTM1uC_VgFF_FWtKtWk-FWM8FSKJesL1geCaj077VtXG9_-rwOqm84pTwWRMYyF6K9tb0TXeO10MfRhVuwjUEIE6RNDXXP0ecKj42XlvuNkb-iX-g_cNAmyWZA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3051940455</pqid></control><display><type>article</type><title>Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?</title><source>Oxford Journals Open Access Collection</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Awosusi, Abiodun E</creator><creatorcontrib>Awosusi, Abiodun E</creatorcontrib><description>Abstract
This article explores how the African Vaccine Manufacturing Accelerator can support the sustainable production of vaccines in Africa. It highlights the value of the accelerator in relation to the Regional Vaccine Manufacturing Collaborative. The author proposes that this novel financing instrument should be well-designed and implemented in line with the targets of the Partnerships for African Vaccine Manufacturing. It should not be a decoupling tool to appease the institutional environment of the global vaccine market, but a sustainable demonstration of the goodwill and commitment of political and technical leaders to ensure equitable access to routine and epidemic-related vaccines in Africa.</description><identifier>ISSN: 1876-3413</identifier><identifier>ISSN: 1876-3405</identifier><identifier>EISSN: 1876-3405</identifier><identifier>DOI: 10.1093/inthealth/ihae032</identifier><identifier>PMID: 38712568</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><ispartof>International health, 2024-05, Vol.16 (5), p.568-570</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. 2024</rights><rights>The Author(s) 2024. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c319t-2f059c5a39c42f3ad6d040c159cfb8c5270cae9b36c9323350ec941fdcd798813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1598,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38712568$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Awosusi, Abiodun E</creatorcontrib><title>Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?</title><title>International health</title><addtitle>Int Health</addtitle><description>Abstract
This article explores how the African Vaccine Manufacturing Accelerator can support the sustainable production of vaccines in Africa. It highlights the value of the accelerator in relation to the Regional Vaccine Manufacturing Collaborative. The author proposes that this novel financing instrument should be well-designed and implemented in line with the targets of the Partnerships for African Vaccine Manufacturing. It should not be a decoupling tool to appease the institutional environment of the global vaccine market, but a sustainable demonstration of the goodwill and commitment of political and technical leaders to ensure equitable access to routine and epidemic-related vaccines in Africa.</description><issn>1876-3413</issn><issn>1876-3405</issn><issn>1876-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqNkTFPwzAQhS0EoqXwA1hQRgZC7ThO4qmqKqCVQCzAal0vTmOUOMVOkPj3pGqJYGOy5ffuu_M9Qi4ZvWVU8qmxbamhasupKUFTHh2RMcvSJOQxFcfDnfEROfP-ndIk40l0SkY8S1kkkmxMlisf9JBgXjiDYIM3QDRWB09guwKw7Zyxm2COqCvtoG1cAEGusem21U6oNZZgja9n5-SkgMrri8M5Ia_3dy-LZfj4_LBazB9D5Ey2YVRQIVEAlxhHBYc8yWlMkfWPxTpDEaUUQcs1T1DyiHNBNcqYFTnmqcwyxidktuduu3Wtc9S2dVCprTM1uC_VgFF_FWtKtWk-FWM8FSKJesL1geCaj077VtXG9_-rwOqm84pTwWRMYyF6K9tb0TXeO10MfRhVuwjUEIE6RNDXXP0ecKj42XlvuNkb-iX-g_cNAmyWZA</recordid><startdate>20240507</startdate><enddate>20240507</enddate><creator>Awosusi, Abiodun E</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240507</creationdate><title>Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?</title><author>Awosusi, Abiodun E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-2f059c5a39c42f3ad6d040c159cfb8c5270cae9b36c9323350ec941fdcd798813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Awosusi, Abiodun E</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Awosusi, Abiodun E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?</atitle><jtitle>International health</jtitle><addtitle>Int Health</addtitle><date>2024-05-07</date><risdate>2024</risdate><volume>16</volume><issue>5</issue><spage>568</spage><epage>570</epage><pages>568-570</pages><issn>1876-3413</issn><issn>1876-3405</issn><eissn>1876-3405</eissn><abstract>Abstract
This article explores how the African Vaccine Manufacturing Accelerator can support the sustainable production of vaccines in Africa. It highlights the value of the accelerator in relation to the Regional Vaccine Manufacturing Collaborative. The author proposes that this novel financing instrument should be well-designed and implemented in line with the targets of the Partnerships for African Vaccine Manufacturing. It should not be a decoupling tool to appease the institutional environment of the global vaccine market, but a sustainable demonstration of the goodwill and commitment of political and technical leaders to ensure equitable access to routine and epidemic-related vaccines in Africa.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>38712568</pmid><doi>10.1093/inthealth/ihae032</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1876-3413 |
ispartof | International health, 2024-05, Vol.16 (5), p.568-570 |
issn | 1876-3413 1876-3405 1876-3405 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11375562 |
source | Oxford Journals Open Access Collection; EZB-FREE-00999 freely available EZB journals |
title | Is the African Vaccine Manufacturing Accelerator a decoupling mechanism? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T15%3A07%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20the%20African%20Vaccine%20Manufacturing%20Accelerator%20a%20decoupling%20mechanism?&rft.jtitle=International%20health&rft.au=Awosusi,%20Abiodun%20E&rft.date=2024-05-07&rft.volume=16&rft.issue=5&rft.spage=568&rft.epage=570&rft.pages=568-570&rft.issn=1876-3413&rft.eissn=1876-3405&rft_id=info:doi/10.1093/inthealth/ihae032&rft_dat=%3Cproquest_pubme%3E3051940455%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3051940455&rft_id=info:pmid/38712568&rft_oup_id=10.1093/inthealth/ihae032&rfr_iscdi=true |